Novo Holdings A/S - 09 Aug 2023 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
10%+ Owner
Signature
/s/ Barbara Fiorini Due, General Counsel, Finance & Operations of Novo Holdings A/S
Issuer symbol
IOBT
Transactions as of
09 Aug 2023
Net transactions value
+$9,999,997
Form type
4
Filing time
11 Aug 2023, 16:31:47 UTC
Previous filing
20 Jul 2023
Next filing
08 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOBT Common Stock Purchase $4,999,998 +2,469,135 +76% $2.02 5,707,467 09 Aug 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Common Stock Warrant (Right to Buy) Purchase $4,999,998 +2,469,135 $2.02 2,469,135 09 Aug 2023 Common Stock 2,469,135 $2.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a combined purchase price of $2.025 for Common Stock and Warrants from Issuer in a private placement.